| Ubitium tapes out universal processor to end embedded computing complexity crisis |
Globe Newswire |
03/09 |
07:05 |
| Bitfarms Expands Leadership Team with Seasoned U.S. Industry Experts to Support HPC/AI Infrastructure Development |
Globe Newswire |
03/09 |
07:05 |
| Skyryse Announces Universal, Emergency Autoland Capability Coming to SkyOS™, Bringing Automated Safe Landings to Both Helicopters and Airplanes |
Globe Newswire |
03/09 |
07:05 |
| Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China |
Globe Newswire |
03/09 |
07:00 |
| Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update |
Globe Newswire |
03/09 |
07:00 |
| Nasdaq to launch equity token design, putting issuers at the center of tokenization |
Globe Newswire |
03/09 |
07:00 |
| 3D Systems Reports Fourth Quarter and Full Year 2025 Financial Results |
Globe Newswire |
03/09 |
07:00 |
| Siris Agrees to Acquire a Majority Stake in TAKKION from Apollo Funds |
Globe Newswire |
03/09 |
07:00 |
| Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights |
Globe Newswire |
03/09 |
07:00 |
| Dianthus Therapeutics Announces Early GO Decision Following Interim Responder Analysis in Phase 3 CAPTIVATE Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
Globe Newswire |
03/09 |
07:00 |
| Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference |
Globe Newswire |
03/09 |
07:00 |
| NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study |
Globe Newswire |
03/09 |
07:00 |
| B2BROKER and Centroid Strengthen Collaboration to Enhance B2TRADER Liquidity and Risk Capabilities |
Globe Newswire |
03/09 |
07:00 |
| Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS) |
Globe Newswire |
03/09 |
07:00 |
| Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients |
Globe Newswire |
03/09 |
07:00 |
| DecisionDx®-Melanoma’s i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Than 5% Risk |
Globe Newswire |
03/09 |
07:00 |
| $SMR Court Notice: NuScale Power Investors are Notified of the Pending Securities Fraud Class Action after Stock Drops 12% -- Contact BFA Law before April 20 Deadline |
Globe Newswire |
03/09 |
06:46 |
| Nova Announces Further High-Grade Gold Discovered at RPM |
Globe Newswire |
03/09 |
06:30 |
| Rare Earth Metals Market to create USD 14.4 Billion of Business Opportunities as EV Magnets and Energy Transition Demand Increased |
Globe Newswire |
03/09 |
06:05 |
| Sant Joan de Déu Hospital Ward upgrades energy technology with Schneider Electric KNX Solutions, cutting energy costs by 40% |
Globe Newswire |
03/09 |
06:01 |
| Quest Software Survey Finds That Over 75 Percent of Global Organizations Are Not Testing Identity Disaster Recovery Frequently Enough |
Globe Newswire |
03/09 |
06:00 |
| ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® (epinephrine nasal spray) Commercialization |
Globe Newswire |
03/09 |
06:00 |
| Auddia Showcases Discovr Radio at 2026 SXSW with Live Demo Listening Events and Brand Activation within the Artist Lounge |
Globe Newswire |
03/09 |
06:00 |
| Mullen Group Ltd. Announces Renewal of Normal Course Issuer Bid |
Globe Newswire |
03/09 |
06:00 |
| ORIGENCE ANNOUNCES DAYMOND JOHN AS KEYNOTE SPEAKER FOR LENDING TECH LIVE ’26 CONFERENCE |
Globe Newswire |
03/09 |
06:00 |
